Page 20 of articles about vaccine

Intervet/Schering-Plough Animal Health announces that it will open today a state-of-the-art production center for veterinary vaccines against bacterial infections. The new facility is located at Biosciences Center Boxmeer, one of the world’s largest veterinary R&D and manufacturing facilities and a cornerstone of the company’s global vaccine R&D and production network.

H1N2, H1N1 and H3N2 are the three influenza A virus subtypes of the Swine Influenza virus contained in GRIPOVAC®3, a new vaccine against swine influenza.

IDT Biologika has developed and is marketing the first swine influenza vaccine - Respiporc Flu3 - registered for protection against the three most clinically significant subtypes of the virus, H1N1, H3N2 and H1N2.

Intervet/Schering-Plough Animal Health today announces that it has received marketing authorization from the European Commission on January 12, 2010 for a single-shot vaccination schedule of its PORCILIS® PCV vaccine against porcine circovirus type 2 (PCV2) infections.

Ingelvac CircoFLEX® - first vaccine against Porcine Circovirus Disease approved in China

Pork CRC supported 4th year animal science honours student at Western Australia’s Murdoch University, Amy Lealiifano, has found that vaccinating boars for the second time with Improvac close to a fortnight before slaughter effectively controls boar taint, while also not blowing out fat levels.

A team of researchers from the China Agricultural University in Beijing have won an award for their evaluation of the performance of the boar taint vaccine Improvac® (Pfizer Animal Health) under Chinese production conditions.

Pfizer Animal Health is First to Develop, Manufacture and Receive USDA Approval

The H1N1 virus has now been found in a Canadian swine herd, and an Iowa State University researcher is ready to produce an H1N1 flu vaccine for pigs.

Acquisition positions Boehringer Ingelheim among the world`s top animal health companies.